Avidity Biosciences Inc ( RNAM) - Key Metrics
Stock symbol RNAM is outdated, potentially delisted? Maybe it is available on other exchange?
RNAM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.01 | -$1.59 | -$1.14 | -$1.17 |
| 2025Q3 | $0.09 | -$1.27 | -$1.13 | -$1.14 |
| 2025Q2 | $0.03 | -$1.21 | -$1.54 | -$1.57 |
| 2025Q1 | $0.01 | -$0.90 | -$0.97 | -$0.99 |
| 2024Q4 | $0.02 | -$0.80 | -$0.78 | -$0.81 |
RNAM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -11.43 |
| 2025Q3 | ? | -14.36 |
| 2025Q2 | ? | -14.96 |
| 2025Q1 | ? | -20.27 |
| 2024Q4 | ? | -22.82 |
RNAM Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | -1.62% | ? |
| 2025Q3 | -1.57% | ? |
| 2025Q2 | -2.16% | ? |
| 2025Q1 | -1.37% | ? |
| 2024Q4 | -1.11% | ? |
RNAM
Price: $72.82
52 week price:
Earnings Per Share: -4.19 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 11.2 billion